Sector: Pharmaceuticals & Biotechnology

Mid Cap

Strides Pharma Share Price

Strides Pharma Science Ltd.

₹872.90

3.25(0.37%)

Invest in STAR with up to 2.50x margin.

Trade with MTF

23rd Feb 2026 | 3:28 PM

NSE : STAR

Open Free Demat Account

Strides Pharma Performance

Price Movement

₹872.90

₹867.85

₹887.80

↘ Today's Low↗ Today's High

1 Year Performance

₹872.90

₹513.05

₹1025.00

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹887.80

Low₹867.85

Open at₹878.00

Prev Close₹869.65

Volumes1.13 L

Avg Price₹876.86

Lower Circuit₹695.75

Upper Circuit₹1,043.55

Historical Performance

3M High₹1,010.30

3M Low₹768.65

1 Yr High₹1,025.00

1 Yr Low₹513.05

3 Yr High₹1,675.00

3 Yr Low₹268.15

5 Yr High₹1,675.00

5 Yr Low₹263.35

Strides Pharma Fundamentals

Market Cap

Above industry Median

8,062.80 Cr.

PE Ratio (TTM)

Below industry Median

15.80

Dividend Yield

Below industry Median

0.50

Net Profit TTM

89.7% incr over last year

511.44

Net Profit Growth

89.7% incr over last year

511.44

PEG Ratio

Above industry Median

0.20

ROE

4341.3% incr over last year

140.81

Operating Revenue TTM

4,725.61

Operating Revenue Growth

4.4% incr over last year

Book Value

Above industry Median

2.90

MFI

MFI is mid-range

56.14

RSI

RSI is mid-range

49.38

EPS (TTM)

390.55

Debt to Equity

0.70

Face Value

Operating Profit Margin Qtr.

17.36

Operating Profit Qtr.

235.94

Net Profit Qtr.

202.11

Operating Revenue Qtr.

1,194.65

PB Ratio

2.90

Strides Pharma Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	553.63	522.15	498.62	555.96	550.92
Operating Expense	472.43	459.93	431.38	488.03	476.82
Operating Profit	81.20	62.22	67.23	67.93	74.10
Depreciation	22.40	21.51	22.14	22.37	20.92
Interest	27.24	29.41	30.45	29.36	34.21
Tax	12.91	-6.65	3.06	12.20	6.44
Net Profit	121.90	32.04	13.35	16.13	14.94

Strides Pharma Technicals

Strides Pharma Science Ltd. EMA & SMA

₹872.90

3.25 (0.37%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹870.8

Day EMA10 ₹869.3

Day EMA12 ₹868.8

Day EMA20 ₹869.5

Day EMA26 ₹871.6

Day EMA50 ₹878.5

Day EMA100 ₹877.6

Day EMA200 ₹869.1

Strides Pharma Support and Resistance

Resistance

First Resistance₹876.10

Second Resistance₹882.55

Third Resistance₹889.90

Support

First Support₹862.30

Second Support₹854.95

Third Support₹848.50

Technical Indicators

Day RSI49.38

Day MFI56.14

Day ADX18.43

Day Commodity Channel Index38.50

William-58.70

Day MACD-2.71

Day MACD Signal Line-5.70

Day ATR34.53

Day ROC125-0.65

Day ROC210.58

Strides Pharma Shareholding Pattern

Held By	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoter	25.8	26.8	28.3	28.3	27.9	27.9
FII	30.1	28.5	28.3	28	28.5	29.5
DII	18.2	16.9	13.7	13.3	13	13.1
Public	25.8	27.8	29.6	30.4	30.6	29.6

Strides Pharma Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	46.85 K	1.18 L	39.76%
Week	91.23 K	2.16 L	42.18%
1 Month	2.01 L	5.93 L	33.97%
6 Month	1.56 L	4.79 L	32.47%

Strides Pharma SWOT Analysis

Strengths22

Weakness3

Opportunity6

Threats1

Benjamin Graham Value Screen

Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE

Strong Performer, Under Radar Stocks (DVM)

Undervalued Growth Stocks

Jim Slater's Zulu Principle (Discover Growth Stocks)

Relative Outperformance versus Industry over 1 Year

Companies with high TTM EPS Growth

Growth Stars: Strongest Annual EPS Performers

Strong QoQ EPS Growth in recent results

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Increasing profits every quarter for the past 3 quarters

Annual Net Profits improving for last 2 years

Companies with decreasing Promoter pledge

Top Gainers

Strides Pharma Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
22 Jul, 2025	4	FINAL	22 Jul, 2025	Equity Share
09 Sep, 2024	2.5	FINAL	09 Sep, 2024	Equity Share
04 Aug, 2023	1.5	FINAL	04 Aug, 2023	Equity Share
05 Aug, 2021	2.5	FINAL	06 Aug, 2021	Equity Share
24 Jul, 2020	2	FINAL	27 Jul, 2020	Equity Share
22 Aug, 2019	12	INTERIM	23 Aug, 2019	Equity Share
19 Jul, 2019	3	FINAL		Equity Share
12 Sep, 2018	2	FINAL		Equity Share
07 Sep, 2017	4.5	FINAL		Equity Share
21 Jul, 2016	4	FINAL		Equity Share

Strides Pharma Stock Comparison

Financials	Corona Remedies Ltd.	Sudeep Pharma Ltd.	Rubicon Research Ltd.	Sai Life Science Ltd.	OneSource Specialty Pharma Ltd.	Sanofi Consumer Healthcare India Ltd.
Price (₹)	₹1,577	₹628.95	₹780	₹968	₹1,320	₹4,075
% Change	3.47%	-5.40%	-0.01%	2.83%	3.96%	0.75%
Revenue TTM (₹ Cr)	-	-	₹1,598.19	₹2,169.86	₹1,419.33	₹798.10
Net Profit TTM (₹ Cr)	-	-	₹206.20	₹332.94	₹20.10	₹217.90
PE TTM	-	-	62.20	61.50	754.90	43.10
1 Year Return	48.29	6.51	60.63	37.17	3.9	-12.48
ROCE	30.24	34.78	34.76	12.51	3.26	-

Similar Stocks

AKUMS

Akums Drugs & Pharmaceuticals Ltd.

₹ 474.00

-0.91%

BLUEJET

Blue Jet Healthcare Ltd

₹ 391.40

+9.99%

CONCORDBIO

Concord Biotech Ltd.

₹ 1103.00

+0.46%

AARTIPHARM

Aarti Pharmalabs Ltd.

₹ 687.60

-1.60%

SUPRIYA

Supriya Lifescience Ltd.

₹ 670.00

-1.17%

ACUTAAS

Acutaas Chemicals Ltd.

₹ 2138.50

+1.52%

ALIVUS

Alivus Life Sciences Ltd.

₹ 901.15

-1.08%

COHANCE

Cohance Lifesciences Ltd.

₹ 315.10

+3.18%

ERIS

Eris Lifesciences Ltd.

₹ 1358.00

+1.16%

SYNGENE

Syngene International Ltd.

₹ 448.60

+1.33%

APLLTD

Alembic Pharmaceuticals Ltd.

₹ 774.90

+1.55%

GRANULES

Granules India Ltd.

₹ 598.00

-0.18%

FDC

FDC Ltd.

₹ 383.00

+3.82%

SHILPAMED

Shilpa Medicare Ltd.

₹ 329.00

+1.29%

JUBLPHARMA

Jubilant Pharmova Ltd.

₹ 900.00

+3.15%

NATCOPHARM

Natco Pharma Ltd.

₹ 886.00

-0.64%

CAPLIPOINT

Caplin Point Laboratories Ltd.

₹ 1739.00

+2.77%

NEULANDLAB

Neuland Laboratories Ltd.

₹ 13507.00

+6.88%

MARKSANS

Marksans Pharma Ltd.

₹ 179.32

+0.53%

SANOFI

Sanofi India Ltd.

₹ 4080.00

+1.34%

PGHL

Procter & Gamble Health Ltd.

₹ 5080.00

+1.21%

JSLL

Jeena Sikho Lifecare Ltd.

₹ 674.90

-2.16%

FAQ's on STAR

What is the current share price of Strides Pharma Science Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Strides Pharma Science Ltd. is ₹ 872.9 on the NSE and ₹ 873.15 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Strides Pharma Science Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Strides Pharma Science Ltd. is approximately ₹ 8062.8 Cr.

What are the PE and PB ratios for Strides Pharma Science Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Strides Pharma Science Ltd. is 15.8, and the Price-to-Book (PB) ratio is 2.9.

What is the 52-Week High and Low for Strides Pharma Science Ltd.?

Over the past 52 weeks, the highest price reached by Strides Pharma Science Ltd. shares was ₹ 1025, and the lowest price was ₹ 513.05.

What is the current dividend yield for Strides Pharma Science Ltd.?

As of 6 June 2025, the dividend yield for Strides Pharma Science Ltd. is 0.5%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Strides Pharma Science Ltd.?

Significant shareholdings in Strides Pharma Science Ltd. typically include entities such as:

Public
FII
Promoter
Mutual Funds
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Strides Pharma Science Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Strides Pharma Science Ltd. is often compared with other major players such as Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs, Corona Remedies, Sudeep Pharma and Curis Lifesciences for analysis and benchmarking.

What is the latest dividend information for Strides Pharma Science Ltd.?

Strides Pharma Science Ltd. last declared a FINAL dividend of ₹ 4 per share for the financial period ending 2025. The record date was set as 2025-07-22, and the payment was/is scheduled around 2025-07-22. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy